Abeona therapeutics reports first quarter 2024 financial results and recent corporate progress

Bla resubmission anticipated in second half of 2024 closed $75 million underwritten offering in may, extending expected cash runway into 2026 cleveland, may 15, 2024 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo) today reported financial results for the first quarter of 2024 and recent corporate progress. “we are grateful to our existing as well as new investors who have demonstrated their support through the recent financing, which has extended our cash runway into 2026, well beyond anticipated regulatory milestones,” said vish seshadri, chief executive officer of abeona.
ABEO Ratings Summary
ABEO Quant Ranking